Subscribe to Newsletter

Subspecialties

Subspecialties Retina

Two Paths to Better Vision

| Michael Schubert

Two research teams have developed very different ways of tackling retinitis pigmentosa, but both hold great promise

Subspecialties Neuro-ophthalmology

A Sidekick for Sight

| Michael Schubert

Object motion detector cell function relies on a unique interneuron and a special ‘sidekick’ recognition protein

Subspecialties Cornea / Ocular Surface

CXL: Seven Years Later

In patients with keratoconus, CXL halts progression up to seven years on

Subspecialties Retina

Edging Closer to a Diagnosis

| Michael Schubert

Peripheral retinal lesions may predict diabetic patients’ risk of disease progression – and ultrawide field imaging could enable a better and earlier early diagnosis

Subspecialties Cornea / Ocular Surface

A Tired Eye Tirade

| Mark Hillen

Why is public awareness of dry eye so disturbingly low, and what can be done to change this?

Subspecialties Imaging & Diagnostics

Positive response to swept-source OCT Cataract and Refractive Imaging Platform at ESCRS

The feedback and reactions to the first public presentation of Heidelberg Engineering’s new Cataract and Refractive Imaging Platform* at the ESCRS in Barcelona were extremely positive. Many leading ophthalmologists visited Heidelberg Engineering’s booth for a hands-on preview of the swept-source OCT Cataract and Refractive Imaging Platform and had the chance to experience its versatility. Have a look at this Eyewire TV to find out more.

Subspecialties Retina

Aflibercept in Europe: Setting New Standards in Retinal Disease Care

Strength and durability in the real world

Subspecialties Retina

Light Years Ahead

| Roisin McGuigan

What if there was an imaging technique that could detect retinal disease processes before any structural damage had even occurred?

Subspecialties Basic & Translational Research

AMD Clinical Trials

| Mark Hillen, Roisin McGuigan

AMD is the leading cause of blindness in developed countries, and the third-leading cause in developing countries.

Subspecialties Retina

Interleukin Forward to a Promising Future in AMD

| Mark Hillen

A novel signaling pathway that leads to choroidal neovascularization has been identified – with obvious therapeutic potential

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: